Senhwa Biosciences, Inc. (TPEX: 6492)
Taiwan
· Delayed Price · Currency is TWD 46.90
-1.30 (-2.70%)
Sep 10, 2024, 1:30 PM CST
Senhwa Biosciences Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 1,167 | 1,319 | 1,619 | 2,033 | 2,369 | 837.28 | Upgrade
|
| Cash & Short-Term Investments | 1,167 | 1,319 | 1,619 | 2,033 | 2,369 | 837.28 | Upgrade
|
| Cash Growth | -19.80% | -18.55% | -20.34% | -14.19% | 182.89% | -31.90% | Upgrade
|
| Accounts Receivable | - | - | - | 0.19 | - | 0.03 | Upgrade
|
| Other Receivables | 22.08 | 21.03 | 8.64 | 7 | 6.4 | 5.77 | Upgrade
|
| Receivables | 22.08 | 21.03 | 8.64 | 7.18 | 6.4 | 5.8 | Upgrade
|
| Prepaid Expenses | 0.81 | 2.08 | 5.51 | 1.62 | 3.38 | 3.05 | Upgrade
|
| Other Current Assets | 6.87 | 4.66 | 4.18 | 3.35 | 4.91 | 3.18 | Upgrade
|
| Total Current Assets | 1,197 | 1,347 | 1,637 | 2,045 | 2,383 | 849.31 | Upgrade
|
| Property, Plant & Equipment | 23.12 | 14.37 | 15.75 | 15.42 | 9.9 | 8.4 | Upgrade
|
| Long-Term Investments | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | Upgrade
|
| Other Intangible Assets | 0.19 | 0.23 | - | 0.07 | - | 0.01 | Upgrade
|
| Other Long-Term Assets | 2.05 | 2.02 | 1.54 | 1.32 | 1.88 | 1.9 | Upgrade
|
| Total Assets | 1,222 | 1,363 | 1,655 | 2,062 | 2,395 | 859.75 | Upgrade
|
| Accrued Expenses | 12.57 | 32.37 | 22.04 | 75.63 | 47.59 | 21.44 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 7.2 | - | Upgrade
|
| Current Portion of Leases | 9.5 | 6.31 | 8.18 | 5.17 | 4.18 | 5.73 | Upgrade
|
| Other Current Liabilities | 2.64 | 4.2 | 2.73 | 1.43 | 2.3 | 2.16 | Upgrade
|
| Total Current Liabilities | 24.71 | 42.89 | 32.95 | 82.23 | 61.27 | 29.32 | Upgrade
|
| Long-Term Debt | - | - | - | - | 2.06 | - | Upgrade
|
| Long-Term Leases | 10.04 | 3.29 | 7.98 | 10.21 | 5.67 | 1.81 | Upgrade
|
| Total Liabilities | 34.75 | 46.18 | 40.93 | 92.44 | 68.99 | 31.13 | Upgrade
|
| Common Stock | 897.44 | 897.44 | 897.44 | 897.44 | 896.58 | 744.99 | Upgrade
|
| Additional Paid-In Capital | 469.58 | 765.88 | 1,116 | 1,444 | 1,790 | 475.16 | Upgrade
|
| Retained Earnings | -132.81 | -296.31 | -349.63 | -329.26 | -354.88 | -391.78 | Upgrade
|
| Treasury Stock | -51.35 | -51.35 | -51.35 | -38.11 | -1.99 | - | Upgrade
|
| Comprensive Income & Other | 4.64 | 1.49 | 1.35 | -5.24 | -3.39 | 0.25 | Upgrade
|
| Shareholders' Equity | 1,188 | 1,317 | 1,614 | 1,969 | 2,326 | 828.61 | Upgrade
|
| Total Liabilities & Equity | 1,222 | 1,363 | 1,655 | 2,062 | 2,395 | 859.75 | Upgrade
|
| Total Debt | 19.54 | 9.6 | 16.16 | 15.38 | 19.11 | 7.54 | Upgrade
|
| Net Cash (Debt) | 1,147 | 1,309 | 1,603 | 2,017 | 2,349 | 829.74 | Upgrade
|
| Net Cash Growth | -20.36% | -18.33% | -20.53% | -14.14% | 183.16% | -32.51% | Upgrade
|
| Net Cash Per Share | 12.87 | 14.68 | 17.97 | 22.50 | 29.75 | 11.14 | Upgrade
|
| Filing Date Shares Outstanding | 89.19 | 89.19 | 88.63 | 89.31 | 89.62 | 74.5 | Upgrade
|
| Total Common Shares Outstanding | 89.19 | 89.19 | 88.63 | 89.31 | 89.62 | 74.5 | Upgrade
|
| Working Capital | 1,172 | 1,304 | 1,605 | 1,963 | 2,322 | 819.99 | Upgrade
|
| Book Value Per Share | 13.31 | 14.77 | 18.21 | 22.05 | 25.96 | 11.12 | Upgrade
|
| Tangible Book Value | 1,187 | 1,317 | 1,614 | 1,969 | 2,326 | 828.6 | Upgrade
|
| Tangible Book Value Per Share | 13.31 | 14.77 | 18.21 | 22.05 | 25.96 | 11.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.